Association Between Platelet Count and Components of Metabolic Syndrome in Geriatric Taiwanese Males

Avogaro, 1967, Associazione di iperlipemia, diabete mellito e obesita’ di medio grado, Acta Diabetol, 4, 572, 10.1007/BF01544100 Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 Zheng, 2009, Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China, Clin Cardiol, 32, 491, 10.1002/clc.20605 Lorenzo, 2006, Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study, Diabetes Care, 29, 625, 10.2337/diacare.29.03.06.dc05-1755 Morgan, 2010, The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK, Diabet Med, 27, 673, 10.1111/j.1464-5491.2010.02912.x Chang, 2010, Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study, Diabet Med, 27, 636, 10.1111/j.1464-5491.2010.03007.x Nagasawa, 2004, Association of white blood cell count and clustered components of metabolic syndrome in Japanese men, Circ J, 68, 892, 10.1253/circj.68.892 Marchesini, 2004, WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes, Diabet Med, 21, 383, 10.1111/j.1464-5491.2004.01115.x Mikhail, 2009, The metabolic syndrome: insulin resistance, Curr Hypertens Rep, 11, 156, 10.1007/s11906-009-0027-4 Jeannette Lee, 2008, The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study, Clin Endocrinol, 69, 225, 10.1111/j.1365-2265.2008.03174.x Franchini, 2008, The metabolic syndrome and the risk of arterial and venous thrombosis, Thromb Res, 122, 727, 10.1016/j.thromres.2007.09.010 Festa, 2000, Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS), Circulation, 102, 42, 10.1161/01.CIR.102.1.42 Frohlich, 2000, Association between C-reactive protein and features of the metabolic syndrome: a population-based study, Diabetes Care, 23, 1835, 10.2337/diacare.23.12.1835 Chen, 2004, Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey, Diabetes Care, 27, 2960, 10.2337/diacare.27.12.2960 Ford, 2003, The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey, Atherosclerosis, 168, 351, 10.1016/S0021-9150(03)00134-5 Recasens, 2005, An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance, J Clin Endocrinol Metab, 90, 112, 10.1210/jc.2004-0708 Fearon, 2008, Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist, Circulation, 117, 2577, 10.1161/CIRCULATIONAHA.108.772491 Oda, 2010, Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese, Intern Med, 49, 117, 10.2169/internalmedicine.49.2670 Pauciullo, 2008, Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome, Metabolism, 57, 563, 10.1016/j.metabol.2007.11.021 Kim, 2006, Association of metabolic syndrome with white blood cell subtype and red blood cells, Endocr J, 53, 133, 10.1507/endocrj.53.133 Ohshita, 2004, Elevated white blood cell count in subjects with impaired glucose tolerance, Diabetes Care, 27, 491, 10.2337/diacare.27.2.491 Tong, 2004, White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes, Diabetes Care, 27, 216, 10.2337/diacare.27.1.216 Von Hundelshausen, 2007, Platelets as immune cells: bridging inflammation and cardiovascular disease, Circ Res., 100, 27, 10.1161/01.RES.0000252802.25497.b7 Stone, 2005, Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options, Am J Cardiol, 96, 53E, 10.1016/j.amjcard.2005.06.006 Jesri, 2005, Platelet and white blood cell counts are elevated in patients with the metabolic syndrome, J Clin Hypertens (Greenwich), 7, 705, 10.1111/j.1524-6175.2005.04809.x Kotani, 2007, Clustered components of the metabolic syndrome and platelet counts in Japanese females, Clin Chem Lab Med, 45, 376, 10.1515/CCLM.2007.063 Lohsoonthorn, 2007, Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand, Diabetes Metab Syndr, 1, 143, 10.1016/j.dsx.2007.05.002 Grant, 2007, Diabetes mellitus as a prothrombotic condition, J Intern Med, 262, 157, 10.1111/j.1365-2796.2007.01824.x Coban, 2007, Platelet activation in subjects with impaired glucose tolerance, Platelets, 18, 591, 10.1080/09537100701609019 Sudic, 2006, High glucose levels enhance platelet activation: involvement of multiple mechanisms, Br J Haematol, 133, 315, 10.1111/j.1365-2141.2006.06012.x Chuo, 2005, Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese, Endocr Res, 31, 39, 10.1080/07435800500229151 Oda, 2009, LDL cholesterol is more strongly associated with metabolic syndrome in Japanese women than in men, Intern Med, 48, 1607, 10.2169/internalmedicine.48.2398 Pentikainen, 2000, Modified LDL—trigger of atherosclerosis and inflammation in the arterial intima, J Intern Med, 247, 359, 10.1046/j.1365-2796.2000.00655.x Zamaklar, 2009, Vascular inflammation: effect of proatherogenic dyslipidemic trio or quartet, Med Pregl, 62, 37 Korporaal, 2006, Platelet activation by low density lipoprotein and high density lipoprotein, Pathophysiol Haemost Thromb, 35, 270, 10.1159/000093220 Akkerman, 2008, From low-density lipoprotein to platelet activation, Int J Biochem Cell Biol, 40, 2374, 10.1016/j.biocel.2008.04.002 Clarke, 1996, Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood, Cytokine, 8, 717, 10.1006/cyto.1996.0095 Kaser, 2001, Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis, Blood, 98, 2720, 10.1182/blood.V98.9.2720 Jovinge, 1998, Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease, Metabolism, 47, 113, 10.1016/S0026-0495(98)90203-7 Grunfeld, 1991, Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells, Metabolism, 40, 894, 10.1016/0026-0495(91)90062-2 Maziere, 1995, Inflammation cytokines and peroxidation of low density lipoproteins (LDL), C R Seances Soc Biol Fil, 189, 811 Spencer, 2002, Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), Hypertension, 40, 61, 10.1161/01.HYP.0000022061.12297.2E Lin, 2007, Impaired glucose tolerance and impaired fasting glucose share similar underlying pathophysiologies, Tohoku J Exp Med, 212, 349, 10.1620/tjem.212.349 Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler Thromb Vasc Biol, 19, 972, 10.1161/01.ATV.19.4.972